Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/02/2010US20100305130 Nasal spray device and method of use thereof
12/02/2010US20100305129 Compositions and methods for inhibiting growth and metastasis of melanoma
12/02/2010US20100305128 Pyrimidinyl-Thiophene Kinase Modulators
12/02/2010US20100305127 Novel compounds
12/02/2010US20100305126 Pyrimidine Inhibitors of Kinase Activity
12/02/2010US20100305125 Salt of abt-263 and solid-state forms thereof
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305122 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305120 Compounds for treating muscular dystrophy
12/02/2010US20100305119 Method for the treatment of anthrax infections
12/02/2010US20100305118 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305117 Substituted pteridines useful for the treatment and prevention of viral infections
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305115 Inhibitors of human immunodeficiency virus replication
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305113 Substituted Imidazopyridazines as Lipid Kinase Inhibitors
12/02/2010US20100305112 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305111 Substituted piperidines
12/02/2010US20100305110 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/02/2010US20100305109 Potassium channel modulators
12/02/2010US20100305108 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305106 Inhibitors of fatty acid uptake and methods of use
12/02/2010US20100305105 Phenylsulfoxyoxazole compound inhibitors of urea transporters
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305103 Genes differentially expressed in bipolar disorder and/or schizophrenia
12/02/2010US20100305102 Heterocycle-substituted piperazino-dihydrothienopyrimidines
12/02/2010US20100305101 Leptin genotype and ß-adrenergic agonists
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305099 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
12/02/2010US20100305098 Methods of use
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305093 Inhibitors of mTOR and Methods of Making and Using
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305091 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
12/02/2010US20100305090 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305088 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
12/02/2010US20100305087 Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility
12/02/2010US20100305086 Pharmaceutical Compositions for the Treatment of Pain
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305083 Substituted porphyrins
12/02/2010US20100305082 Use of FKBPL gene to identify a cause of infertility
12/02/2010US20100305081 Organo-gel formulations for therapeutic applications
12/02/2010US20100305080 Novel Crystalline Salts of Montelukast
12/02/2010US20100305079 Method of Treating Human Preeclampsia Employing Resibufagenin
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010US20100305077 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
12/02/2010US20100305076 Methods of treatment for ulcerative colitis
12/02/2010US20100305075 Composition and method of treating hearing loss
12/02/2010US20100305074 Niacin-based pharmaceutical compositions
12/02/2010US20100305073 Amide compounds as boosters of antivirals
12/02/2010US20100305072 Substituted Tetracycline Compounds
12/02/2010US20100305071 Methods for improving healing of an oral lesion using a glycerophosphate salt
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305069 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010US20100305068 Compounds and methods for modulating protein trafficking
12/02/2010US20100305067 Antibacterial condensed thiazoles
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305065 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
12/02/2010US20100305063 Water-Soluble Iron Carbohydrate Derivative Complexes, The Preparation Thereof, And Medicaments Comprising Them
12/02/2010US20100305062 Use of alginate oligomers in combating biofilms
12/02/2010US20100305061 Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
12/02/2010US20100305060 Nucleoside Prodrugs and Uses Thereof
12/02/2010US20100305059 Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
12/02/2010US20100305058 Individualized cancer treatments
12/02/2010US20100305057 Synergistic pharmaceutical combination for the treatment of cancer
12/02/2010US20100305056 Cysteine protease inhibitors for the treatment of parasitic disease
12/02/2010US20100305055 Combinations of polyene fungicide with cationic surfactants
12/02/2010US20100305054 Concentrated aqueous azalide formulations
12/02/2010US20100305052 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/2010US20100305048 Novel use of cytokine inhibitors
12/02/2010US20100305043 Ccl18 and ccl3 methods and compositions for detecting and treating cancer
12/02/2010US20100305036 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305033 Hydroxyalkyl starch derivatives and process for their preparation
12/02/2010US20100305030 Nanoparticles of therapeutic agents having low water solubility
12/02/2010US20100305022 Low molecular weight heparin composition and uses thereof
12/02/2010US20100304484 Use of Alginate Matrices to Control Cell Growth
12/02/2010US20100303940 Synergistic pest-control compositions
12/02/2010US20100303934 Methods and compositions for nerve regeneration
12/02/2010US20100303932 Method for Attenuating the Effects of Botulinum Toxin
12/02/2010US20100303928 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
12/02/2010US20100303926 Organic compounds
12/02/2010US20100303922 Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303919 Pharmaceutical compositions comprising fluvastatin
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303916 Enhanced drug delivery with orientable particles
12/02/2010US20100303913 Method for Nanoencapsulation
12/02/2010US20100303912 Nanocell Drug Delivery System
12/02/2010US20100303908 Pharmaceutical composition comprising desloratadine
12/02/2010US20100303907 Standardized plant extract, process for obtaining the same and uses thereof
12/02/2010US20100303906 Solid dosage forms of valsartan and amlodipine and method of making same
12/02/2010US20100303905 Orally Disintegrating Tablet Compositions of Lamotrigine
1 ... 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 ... 7860